studi
aim
investig
preval
clinic
relev
viral
find
multiplex
pcr
nasopharynx
clinic
septic
patient
winter
season
week
influenza
epidem
period
januarymarch
consecut
adult
patient
suspect
septic
n
analyz
cultur
blood
nasopharynx
plu
multiplex
pcr
respiratori
virus
nasopharyng
specimen
result
compar
microbiolog
analys
order
part
standard
care
winter
season
viral
respiratori
pathogen
mainli
influenza
viru
human
metapneumoviru
coronaviru
respiratori
syncyti
viru
clinic
underdiagnos
patient
posit
multiplex
pcr
assay
first
four
week
influenza
epidem
test
influenza
order
clinician
indic
low
awar
epidem
start
nasopharyng
find
streptococcu
pneumonia
haemophilu
influenza
cultur
correl
pneumonia
diagnosi
patient
laboratori
sign
viral
coinfect
common
rare
suspect
clinician
role
respiratori
viral
infect
patient
present
clinic
pictur
sepsi
underestim
specif
antivir
treatment
might
benefici
case
may
reduc
spread
hospit
set
diagnos
viral
infect
may
promot
reduct
unnecessari
antibiot
use
also
tool
decis
concern
patient
logist
order
minim
exposur
suscept
patient
personnel
respiratori
tract
common
focu
infect
septic
patient
adult
communityacquir
pneumonia
cap
bacteri
etiolog
establish
case
depend
definit
method
use
pneumonia
often
found
bacteria
follow
h
influenza
mycoplasma
pneumonia
rare
found
agent
legionella
pneumophila
chlamydophila
pneumonia
coxiella
burnetti
sever
respiratori
virus
may
also
caus
sever
respiratori
diseas
includ
cap
mainli
children
also
adult
well
known
influenza
b
virus
respiratori
syncyti
viru
coronaviru
human
metapneumoviru
parainfluenza
virus
type
adenoviru
enterovirus
rhinoviru
human
bocaviru
inde
viral
infect
estim
caus
around
million
annual
case
cap
worldwid
mani
virus
season
variat
pattern
caus
epidem
often
peak
winter
earli
spring
viral
respiratori
infect
may
predispos
bacteri
electron
supplementari
materi
onlin
version
articl
contain
supplementari
materi
avail
author
user
infect
damag
respiratori
epithelium
well
viralbacteri
interact
exampl
influenza
viru
enhanc
pathogen
pneumonia
staphylococcu
aureu
h
influenza
hand
inhibit
pathogen
other
pneumonia
c
pneumonia
use
molecular
techniqu
becom
evid
viral
infect
present
around
cap
regardless
sever
viral
coinfect
cap
shown
increas
diseas
sever
length
stay
hospit
patient
pneumonia
requir
intens
care
mix
viralbacteri
infect
demonstr
highest
mortal
rate
least
one
studi
commerci
multiplex
test
continu
develop
allow
rapid
etiolog
diagnosi
wide
rang
respiratori
virus
bacteria
diagnos
viral
respiratori
infect
may
help
reduc
admiss
length
stay
use
antibiot
treatment
case
target
antivir
treatment
test
optim
first
day
infect
viral
load
high
clinic
signific
viral
find
alway
determin
respiratori
virus
like
rhinoviru
persist
young
children
week
clinic
infect
though
persist
longterm
carriag
seem
less
frequent
adult
definit
criteria
sepsi
chang
year
current
sepsi
defin
blifethreaten
organ
dysfunct
caus
dysregul
host
respons
infectionand
said
present
patient
infect
point
sofascor
clinic
viewpoint
patient
suspect
septic
sudden
onset
chill
fever
accompani
abnorm
vital
sign
increas
respiratori
rate
lower
oxygen
satur
tachycardia
hypotens
alter
mentat
gener
malais
laboratori
find
increas
leucocyt
creactiv
protein
lactat
procalcitonin
support
suspicion
broadspectrum
antibiot
treatment
start
clinic
suspicion
bacteri
sepsi
accord
preliminari
diagnosi
treatment
later
modifi
accord
result
cultur
microbiolog
detect
method
infect
biomark
imag
case
origin
etiolog
infect
establish
emerg
depart
clinic
symptom
sign
help
fulli
reliabl
inflammatori
respons
sepsi
may
caus
symptom
sign
mislead
exampl
bacterem
urinari
tract
infect
may
present
predomin
respiratori
symptom
sign
warrant
broad
test
earli
care
studi
conduct
winter
season
pragmat
investig
clinic
relev
nasopharyng
viral
bacteri
find
clinic
septic
patient
suspect
respiratori
focu
sepsi
unknown
origin
sever
sepsi
studi
skaraborg
nine
month
septemb
june
perform
prospect
consecut
epidemiolog
studi
investig
incid
commun
onset
sever
sepsi
septic
shock
adult
skaraborg
rural
area
sweden
popul
singl
public
hospit
skaraborg
hospit
serv
popul
studi
inclus
criteria
resid
skaraborg
year
older
treat
within
h
admiss
intraven
antibiot
clinic
suspicion
sepsi
studi
breal
lifestudi
formal
criteria
sepsi
fulfil
blood
cultur
drawn
patient
start
antibiot
treatment
nasopharynx
cultur
perform
patient
suspect
focu
respiratori
tract
sepsi
unknown
focu
cultur
done
accord
clinic
judgment
treat
physician
patient
evalu
protocol
presenc
develop
sever
sepsi
septic
shock
accord
swedish
definit
criteria
studi
approv
region
ethic
committe
gothenburg
present
studi
part
epidemiolog
studi
sever
sepsi
carri
bthe
flu
seasonin
patient
admit
hospit
januari
march
review
complet
patient
record
patient
perform
accord
protocol
one
infecti
diseas
specialist
lrl
clinic
relev
estim
clinic
note
sudden
onset
respiratori
symptom
dri
product
cough
short
breath
congest
fever
imag
show
new
infiltr
discharg
diagnosi
contain
respiratori
infect
sampl
nasopharynx
perform
use
flock
swab
univers
transport
medium
eswab
copan
studi
patient
suspect
septic
lower
respiratori
tract
infect
sepsi
unknown
focu
result
obtain
swab
compar
nasopharyng
aspir
specimen
use
tradit
npcultur
accord
convent
method
store
sampl
plate
within
h
collect
plate
read
h
incub
target
organ
pneumonia
h
influenza
catarrhali
betahemolyt
streptococci
group
c
g
growth
speci
report
observ
pure
cultur
store
sampl
analyz
within
three
month
use
either
two
differ
viral
respiratori
multiplex
pcr
test
fig
two
set
blood
cultur
bactalert
biomerieux
drawn
patient
initi
intraven
antibiot
treatment
separ
flock
nasopharyng
swab
eswab
copan
use
routin
test
influenza
b
virus
respiratori
syncyti
viru
tripl
viral
test
pneumonia
collect
discret
treat
physician
swab
transport
ml
nacl
use
inhous
pcr
test
result
tripl
viral
pcr
test
report
within
hour
also
use
comparison
result
obtain
later
sampl
collect
analyz
commerci
test
see
part
studi
analysi
pneumonia
perform
nasopharyng
sampl
probebas
labdevelop
realtim
pcr
detect
adhesin
gene
pneumonia
pcr
assay
run
analyz
interpret
rotorgen
instrument
qiagen
nasopharyng
sampl
origin
tube
prepipet
microlab
starlet
hamilton
robot
switzerland
extract
total
nucleic
acid
extract
perform
magna
pure
instrument
roch
appli
scienc
use
dna
viral
na
small
volum
kit
protocol
pathogen
univers
sampl
volum
elut
volum
sampl
extract
nucleic
acid
mix
pcr
reagent
qiagil
qiagen
hilden
germani
analysi
sampl
collect
winter
found
fig
januari
februari
n
broadspectrum
commerci
multiplex
realtim
pcr
assay
detect
virus
four
bacteria
use
respifind
smart
kit
pathofind
netherland
respifind
design
detect
respiratori
syncyti
viru
type
b
adenoviru
human
metapneumoviru
influenza
b
virus
rhinoviru
enterovirus
parainfluenza
virus
type
human
bocaviru
coronaviru
type
pneumonia
l
pneumophila
bordetella
pertussi
c
pneumonia
pcr
assay
run
analyz
interpret
rotorgen
instrument
qiagen
one
sampl
gave
result
exclud
studi
total
multiplex
result
use
final
analysi
sampl
collect
februari
march
n
analyz
commerci
multiplex
realtim
pcr
assay
detect
respiratori
virus
anyplex
ii
rv
seegen
korea
kit
detect
respiratori
syncyti
viru
type
b
adenoviru
human
metapneumoviru
influenza
b
virus
rhinoviru
enterovirus
parainfluenza
virus
type
human
bocaviru
coronaviru
type
pcr
assay
run
realtim
pcr
system
biorad
franc
analyz
interpret
use
bseegen
viewersoftwar
seegen
five
sampl
invalid
exclud
leav
result
anyplex
ii
pcr
final
analysi
total
clinic
np
sampl
analyz
multiplex
pcr
swedish
infecti
diseas
societi
nation
guidelin
defin
pneumonia
bsymptom
sign
consist
acut
lower
respiratori
infect
combin
radiolog
find
compat
diseas
updat
onlin
swedish
diagnosi
pneumonia
studi
made
symptom
sign
consist
acut
lower
respiratori
infect
find
within
first
h
new
infiltr
chest
xray
ct
scan
influenza
viru
common
find
detect
studi
patient
period
clinician
order
tripl
viral
test
influenza
b
virus
respiratori
syncyti
viru
patient
posit
influenza
viru
influenza
b
viru
respiratori
syncyti
viru
first
three
studi
week
one
clinic
request
test
posit
influenza
viru
compar
six
studi
group
first
four
week
influenza
epidem
clinic
request
test
influenza
viru
indic
earli
influenza
epidem
awar
among
clinician
flu
season
start
low
fig
routin
tripl
viral
test
influenza
b
virus
respiratori
syncyti
viru
avail
clinician
request
patient
turn
posit
virus
studi
analysi
pathofind
multiplex
pcr
use
first
patient
studi
posit
pneumonia
five
case
two
patient
also
test
posit
clinic
avail
test
latter
part
studi
pcr
pneumonia
includ
multiplex
pcr
one
addit
patient
posit
pneumonia
routin
pcr
test
convent
cultur
nasopharynx
cultur
patient
posit
bacteria
tabl
total
patient
posit
respiratori
viru
bacteria
bacteria
often
associ
viral
respiratori
pathogen
pneumonia
tabl
two
set
blood
cultur
drawn
initi
intraven
antibiot
treatment
patient
patient
posit
true
bacteri
pathogen
bacteri
speci
aureu
n
e
coli
n
pneumonia
n
klebsiella
pneumonia
n
pyogen
n
other
speci
four
patient
patient
find
one
two
respiratori
virus
respiratori
tract
initi
suspect
focu
infect
sepsi
unknown
focu
focu
tabl
accord
patient
record
initi
clinic
suspicion
respiratori
viral
infect
part
clinic
pictur
case
even
though
studi
occur
well
known
influenza
season
emerg
depart
studi
patient
posit
influenza
viru
initi
suspect
binfluenzaor
bvirosi
time
hospit
anoth
altogeth
clinic
suspect
influenza
test
routin
analysi
patient
posit
either
human
metapneumoviru
respiratori
syncyti
viru
clinic
test
suspicion
viral
infect
yet
patient
record
respiratori
symptom
document
mani
patient
posit
influenza
viru
posit
human
metapneumoviru
respiratori
syncyti
viru
patient
fever
test
posit
influenza
viru
document
respiratori
tract
symptom
find
rhinoviru
enterovirus
coronaviru
human
bocaviru
less
often
link
respiratori
diseas
often
found
patient
infect
outsid
respiratori
tract
infect
tabl
patient
posit
viral
agent
fulfil
least
one
swedish
criteria
sever
sepsi
septic
shock
fourteen
group
new
pulmonari
infiltr
bacteri
find
pneumonia
n
pneumonia
n
h
influenza
n
correl
pneumonia
case
one
patient
posit
h
influenza
coinfect
pneumonia
suffer
sever
sepsi
die
one
day
icu
anoth
posit
pneumonia
coinfect
neisseria
meningitidi
clinic
mild
cours
find
catarrhali
aureu
mrsa
enterobacteriacea
spp
betahemolyt
winter
season
patient
suspect
sepsi
test
nasopharynx
cultur
multiplex
pcr
respiratori
virus
find
pneumonia
h
influenza
strongli
correl
pneumonia
patient
pneumonia
also
viral
find
mainli
influenza
viru
human
metapneumoviru
apart
viral
find
pathofind
multiplex
pcr
test
detect
five
case
pneumonia
five
pneumonia
one
also
grew
h
influenza
rapidli
fatal
cours
one
also
grew
neisseria
meningitidi
mild
cours
hmpv
human
metapneumoviru
rsv
respiratori
syncyti
viru
type
b
streptococci
group
c
g
bacteria
less
often
associ
pneumonia
pneumonia
indic
new
infiltr
chest
xray
ct
scan
demonstr
studi
patient
median
age
year
wherebi
men
anoth
eight
patient
could
determin
whether
new
infiltr
patient
chest
xray
perform
patient
pneumonia
posit
nasopharynx
respiratori
viru
bacteria
common
agent
influenza
viru
n
pneumonia
n
h
influenza
n
human
metapneumoviru
n
pneumonia
n
respiratori
syncyti
viru
type
b
n
patient
cofind
bacteria
plu
virus
one
patient
cofind
h
influenza
pneumonia
tabl
found
viral
infect
often
neglect
populationbas
breal
lifestudi
suspect
septic
patient
studi
perform
winter
period
refer
bthe
flu
season
respiratori
viral
infect
preval
result
increas
clinic
suspicion
yet
first
four
week
influenza
epidem
clinic
sampl
request
materi
viral
respiratori
infect
initi
suspect
clinician
patient
viral
find
multiplex
pcr
especi
true
crp
mgl
new
infiltr
chest
xray
indic
pneumonia
underestim
may
lead
nosocomi
spread
outbreak
viral
respiratori
infect
previous
experienc
hospit
may
also
lead
overus
antibiot
well
underus
antivir
especi
risk
group
might
benefit
treatment
comprehens
studi
bacterialvir
respiratori
tract
ill
three
winter
season
falsey
et
al
influenza
viru
common
viral
find
appear
studi
sampl
almost
two
week
earlier
clinic
sampl
case
influenza
viru
infect
influenza
viru
initi
suspect
sole
caus
contribut
factor
acut
ill
respiratori
syncyti
viru
human
metapneumoviru
may
caus
critic
respiratori
ill
pneumonia
children
also
elderli
exampl
human
metapneumoviru
found
caus
agent
outbreak
pneumonia
among
elderli
institut
netherland
studi
human
metapneumoviru
slightli
common
find
respiratori
syncyti
viru
especi
patient
long
histori
fever
respiratori
tract
congest
combin
radiolog
sign
pneumonia
nasopharyng
cultur
gener
discourag
recommend
etiolog
diagnosi
pneumonia
howev
swedish
studi
et
al
good
correl
nasopharyng
find
bacteria
etiolog
pneumonia
seen
previou
swedish
studi
studi
patient
emerg
depart
suspect
septic
strong
correl
nasopharyng
find
pneumonia
h
influenza
xray
find
new
infiltr
indic
pneumonia
bacteria
found
nasopharynx
patient
nonrespiratori
infect
infect
rare
found
patient
respiratori
tract
infect
pneumonia
studi
result
impli
nasopharyng
find
pneumonia
h
influenza
sepsi
patient
consid
care
patient
treatment
recent
publish
paper
bjarnason
et
al
demonstr
good
correl
realtim
pcr
find
pneumonia
h
influenza
pneumonia
diagnosi
adult
also
build
support
clinic
relev
upper
respiratori
bacteri
find
coinfect
bacteria
respiratori
virus
mainli
pneumonia
influenza
respiratori
syncyti
viru
found
patient
cap
depend
diagnost
method
use
higher
end
reflect
studi
nasopharyng
cultur
includ
etiolog
diagnosi
use
nasopharyng
sampl
found
indic
viralbacteri
coinfect
proport
believ
underestim
studi
falsey
et
al
pneumonia
bacteria
often
associ
pneumonia
viral
coinfect
mani
patient
pneumonia
pneumonia
nasopharynx
posit
respiratori
viru
mainli
influenza
viru
also
human
metapneumoviru
two
youngest
patient
pneumonia
sever
sepsi
age
year
respect
posit
pneumonia
human
metapneumoviru
nasopharynx
pathogen
could
demonstr
routin
cultur
clinic
set
often
difficult
determin
whether
patient
respiratori
symptom
viral
infect
bacteri
infect
mix
viralbacteri
infect
constel
clinic
symptom
vital
sign
biomark
white
blood
cell
count
creactiv
protein
procalcitonin
adequ
sensit
specif
new
tool
improv
predict
patient
benefit
antibiot
treatment
urgent
need
recent
whole
blood
analysi
identif
host
gene
activ
profil
abl
discrimin
viral
infect
bacteri
infect
high
accuraci
sever
ill
infant
describ
herberg
et
al
adult
lower
respiratori
tract
infect
similar
techniqu
seem
abl
discrimin
viral
bacteri
infect
much
better
procalcitonin
shown
suarez
et
al
studi
mix
viralbacteri
infect
also
elicit
characterist
gene
activ
profil
studi
support
increas
test
respiratori
virus
patient
believ
septic
especi
present
respiratori
tract
symptom
current
technolog
result
obtain
within
hour
impact
clinic
decis
patient
logist
emerg
depart
cost
effect
investig
viral
diagnosi
may
lead
fewer
admiss
less
antibiot
treatment
bacteri
pneumonia
suspect
demonstr
may
also
decreas
viral
exposur
admit
patient
patient
influenza
b
may
benefit
antivir
treatment
alon
conjunct
antibacteri
treatment
bacteri
pneumonia
suspect
demonstr
perhap
even
reduc
viral
contagi
even
neutropen
patient
viral
find
favor
outcom
first
day
may
safe
allow
discontinu
antibiot
treatment
studi
sever
limit
singlecent
studi
perform
one
winter
period
studi
primarili
etiolog
studi
respiratori
tract
infect
take
ongo
antibiot
treatment
account
routin
sampl
nasopharynx
perform
albeit
use
flock
swab
better
yield
sputum
nasopharyng
aspir
analyz
molecular
techniqu
would
expect
higher
yield
bacteria
virus
weak
open
inclus
base
clinic
suspicion
sepsi
without
specif
criteria
yet
anoth
subject
involv
decid
relev
find
role
viral
find
play
alon
conjunct
bacteri
find
show
correl
find
clinic
entiti
yet
major
find
seem
correl
well
respiratori
tract
infect
therefor
believ
conclus
signific
viral
diseas
sever
ill
patient
underdiagnos
clinician
warrant
diagnos
infect
earli
may
help
clinic
decis
make
process
therebi
patient
found
viral
respiratori
pathogen
underdiagnos
sever
ill
patient
suspect
septic
mani
present
clinic
symptom
respiratori
tract
may
lead
nosocomi
spread
viral
respiratori
infect
unnecessari
use
antibiot
underus
antivir
hospit
set
furthermor
found
correl
nasopharyng
find
pneumonia
h
influenza
pneumonia
patient
suspect
sepsi
though
sensit
low
specif
high
light
diseas
sever
low
analysi
cost
studi
support
use
admiss
nasopharyng
cultur
part
diagnost
bundl
sepsi
patient
extend
use
molecular
test
could
improv
diagnosi
patient
care
clinic
outcom
patient
suspicion
sepsi
decreas
risk
nosocomi
infect
greatli
appreci
mr
annalena
emanuelssonloft
scrutin
layout
articl
studi
support
grant
region
fund
clinic
research
fund
skaraborg
hospit
unilab
r
fund
conflict
interest
author
declar
conflict
interest
relat
studi
ethic
approv
studi
approv
region
ethic
committe
gothenburg
patient
close
rel
receiv
oral
written
inform
epidemiolog
sepsi
studi
initi
sampl
done
part
standard
medic
care
blood
cultur
cultur
respiratori
tract
clinic
indic
requir
individu
consent
inform
consent
inform
consent
waiv
observ
natur
studi
open
access
articl
distribut
term
creativ
comm
on
attribut
intern
licens
http
permit
unrestrict
use
distribut
reproduct
medium
provid
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licens
indic
chang
made
